Rui Avelar
CIK 1432063 · See Remarks · last filed 2026-03-20
Rui Avelar is a corporate insider who has filed 29 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing shows the insider sold $14.8K of EOLS on Mar 20, 2026. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.88M
3
29
-$1.91M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EOLS | See Remarks | 427,423 | $6.73 | $2.88M | -$1.91M | 25 | 2026-03-20 |
| ANGIOTECH PHARMACEUTICALS INC (ANPI) Delisted | Chief Medical Officer | — | — | — | $0 | 3 | 2010-03-09 |
| ANGIOTECH PHARMACEUTICALS INC (JRT) Delisted | Chief Medical Officer | — | — | — | $0 | 1 | 2008-12-10 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-20 | EOLS | Sell (S) | −3,119 | -$14.8K | EDGAR |
| 2026-03-18 | EOLS | Mixed | −21,192 | -$146.6K | EDGAR |
| 2026-02-19 | EOLS | Grant (A) | +94,913 | $0 | EDGAR |
| 2025-12-29 | EOLS | Sell (S) | −2,261 | -$16.2K | EDGAR |
| 2025-05-14 | EOLS | Sell (S) | −3,385 | -$33.4K | EDGAR |
| 2025-03-20 | EOLS | Sell (S) | −27,904 | -$369.9K | EDGAR |
| 2025-03-11 | EOLS | Grant (A) | +23,776 | $0 | EDGAR |
| 2024-12-26 | EOLS | Sell (S) | −2,252 | -$24.4K | EDGAR |
| 2024-05-14 | EOLS | Sell (S) | −3,441 | -$43.8K | EDGAR |
| 2024-03-21 | EOLS | Sell (S) | −27,603 | -$384.3K | EDGAR |